Response to imatinib (patients were categorized by their response at the 12th month and by their best overall response)
| Response . | Patients with ACAs, N = 21 (%) . | Patients without ACAs, N = 357 (%) . | P . |
|---|---|---|---|
| CHR | |||
| Overall | 21 (100) | 350 (98) | 1.00 |
| CCgR | |||
| 12th mo | 12 (57) | 267 (75) | .12 |
| Overall | 15 (71) | 317 (89) | .03 |
| MMolR | |||
| 12th mo | 10 (48) | 205 (57) | .50 |
| Overall | 14 (67) | 306 (86) | .03 |
| Response . | Patients with ACAs, N = 21 (%) . | Patients without ACAs, N = 357 (%) . | P . |
|---|---|---|---|
| CHR | |||
| Overall | 21 (100) | 350 (98) | 1.00 |
| CCgR | |||
| 12th mo | 12 (57) | 267 (75) | .12 |
| Overall | 15 (71) | 317 (89) | .03 |
| MMolR | |||
| 12th mo | 10 (48) | 205 (57) | .50 |
| Overall | 14 (67) | 306 (86) | .03 |